Rifaximin Plus Lactulose Versus Lactulose Alone for the Treatment of Hepatic Encephalopathy: a Double Blind Randomized Trial

NCT01218568 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Hepatic Encephalopathy

Interventions

DRUG: Rifaximin plus lactulose
DRUG: Lactulose

Sponsor

Institute of Liver and Biliary Sciences, India